{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:25Z","timestamp":1790352505310,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Natural Science Foundation of Shandong Province , China.","award":["ZR2012HL35"],"award-info":[{"award-number":["ZR2012HL35"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13014-016-0589-7","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T02:00:49Z","timestamp":1454637649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice"],"prefix":"10.1186","volume":"11","author":[{"given":"Minghuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"issue":"9","key":"589_CR1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.6004\/jnccn.2008.0061","volume":"6","author":"JA Ajani","year":"2008","unstructured":"Ajani JA. Gastroesophageal cancers: progress and problems. J Natl Compr Cancer Netw. 2008;6(9):813\u20134.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"589_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gtc.2009.01.008","volume":"38","author":"GD Eslick","year":"2009","unstructured":"Eslick GD. Epidemiology of esophageal cancer. Gastroenterol Clin North Am. 2009;38(1):17\u201325. doi: 10.1016\/j.gtc.2009.01.008 . vii.","journal-title":"Gastroenterol Clin North Am"},{"issue":"17","key":"589_CR3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","volume":"281","author":"JS Cooper","year":"1999","unstructured":"Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson Jr JA, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85\u201301). Radiation Therapy Oncology Group. JAMA. 1999;281(17):1623\u20137.","journal-title":"JAMA"},{"issue":"5","key":"589_CR4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.20.5.1167","volume":"20","author":"BD Minsky","year":"2002","unstructured":"Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94\u201305) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20(5):1167\u201374.","journal-title":"J Clin Oncol"},{"issue":"4","key":"589_CR5","first-page":"153","volume":"3","author":"K Higuchi","year":"2009","unstructured":"Higuchi K, Koizumi W, Tanabe S, Sasaki T, Katada C, Azuma M, et al. Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res. 2009;3(4):153\u201361.","journal-title":"Gastrointest Cancer Res"},{"issue":"2","key":"589_CR6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.radonc.2013.09.008","volume":"109","author":"X Meng","year":"2013","unstructured":"Meng X, Wang J, Sun X, Wang L, Ye M, Feng P, et al. Cetuximab in combination with chemoradiotherapy in Chinese patients with non-resectable, locally advanced esophageal squamous cell carcinoma: a prospective, multicenter phase II trail. Radiother Oncol. 2013;109(2):275\u201380. doi: 10.1016\/j.radonc.2013.09.008 .","journal-title":"Radiother Oncol"},{"issue":"2","key":"589_CR7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijrobp.2006.09.015","volume":"67","author":"XS Gao","year":"2007","unstructured":"Gao XS, Qiao X, Wu F, Cao L, Meng X, Dong Z, et al. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys. 2007;67(2):389\u201396. doi: 10.1016\/j.ijrobp.2006.09.015 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"589_CR8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ijrobp.2008.04.062","volume":"73","author":"MR Button","year":"2009","unstructured":"Button MR, Morgan CA, Croydon ES, Roberts SA, Crosby TD. Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;73(3):818\u201323. doi: 10.1016\/j.ijrobp.2008.04.062 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"35","key":"589_CR9","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1200\/JCO.2007.13.2191","volume":"25","author":"KE Rosenzweig","year":"2007","unstructured":"Rosenzweig KE, Sura S, Jackson A, Yorke E. Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol. 2007;25(35):5557\u201361. doi: 10.1200\/jco.2007.13.2191 .","journal-title":"J Clin Oncol"},{"issue":"2","key":"589_CR10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.radonc.2011.10.003","volume":"102","author":"B Xia","year":"2012","unstructured":"Xia B, Chen GY, Cai XW, Zhao JD, Yang HJ, Fan M, et al. Is involved-field radiotherapy based on CT safe for patients with limited-stage small-cell lung cancer? Radiother Oncol. 2012;102(2):258\u201362. doi: 10.1016\/j.radonc.2011.10.003 .","journal-title":"Radiother Oncol"},{"issue":"1","key":"589_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","volume":"89","author":"T Illidge","year":"2014","unstructured":"Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, et al. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2014;89(1):49\u201358. doi: 10.1016\/j.ijrobp.2014.01.006 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"589_CR12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","volume":"89","author":"L Specht","year":"2014","unstructured":"Specht L, Yahalom J, Illidge T, Berthelsen AK, Constine LS, Eich HT, et al. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys. 2014;89(4):854\u201362. doi: 10.1016\/j.ijrobp.2013.05.005 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"589_CR13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ijrobp.2009.02.078","volume":"76","author":"KL Zhao","year":"2010","unstructured":"Zhao KL, Ma JB, Liu G, Wu KL, Shi XH, Jiang GL. Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary? Int J Radiat Oncol Biol Phys. 2010;76(2):446\u201351. doi: 10.1016\/j.ijrobp.2009.02.078 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"589_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1748-717X-9-64","volume":"9","author":"X Zhang","year":"2014","unstructured":"Zhang X, Li M, Meng X, Kong L, Zhang Y, Wei G, et al. Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Radiat Oncol. 2014;9:64. doi: 10.1186\/1748-717x-9-64 .","journal-title":"Radiat Oncol"},{"issue":"10","key":"589_CR15","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","volume":"25","author":"L Bedenne","year":"2007","unstructured":"Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25(10):1160\u20138. doi: 10.1200\/jco.2005.04.7118 .","journal-title":"J Clin Oncol"},{"issue":"8","key":"589_CR16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/jjco\/hyr069","volume":"41","author":"Y Kawaguchi","year":"2011","unstructured":"Kawaguchi Y, Nishiyama K, Miyagi K, Suzuki O, Ito Y, Nakamura S. Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer. Jpn J Clin Oncol. 2011;41(8):1007\u201312. doi: 10.1093\/jjco\/hyr069 .","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"589_CR17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2014.11.004","volume":"113","author":"H Yamashita","year":"2014","unstructured":"Yamashita H, Omori M, Takenaka R, Okuma K, Kobayashi R, Ohtomo K, et al. Involved-field irradiation concurrently combined with nedaplatin\/5-fluorouracil for inoperable esophageal cancer on basis of (18)FDG-PET scans: a phase II study. Radiother Oncol. 2014;113(2):182\u20137. doi: 10.1016\/j.radonc.2014.11.004 .","journal-title":"Radiother Oncol"},{"issue":"4","key":"589_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00311252","volume":"25","author":"T Nishihira","year":"1995","unstructured":"Nishihira T, Sayama J, Ueda H, Sugawara K, Takano R, Sagawa J, et al. Lymph flow and lymph node metastasis in esophageal cancer. Surg Today. 1995;25(4):307\u201317.","journal-title":"Surg Today"},{"issue":"3","key":"589_CR19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00268-008-9781-8","volume":"33","author":"S Motoyama","year":"2009","unstructured":"Motoyama S, Maruyama K, Sato Y, Usami S, Nakatsu T, Saito H, et al. Status of involved lymph nodes and direction of metastatic lymphatic flow between submucosal and t2-4 thoracic squamous cell esophageal cancers. World J Surg. 2009;33(3):512\u20137. doi: 10.1007\/s00268-008-9781-8 .","journal-title":"World J Surg"},{"issue":"6","key":"589_CR20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0022-5223(03)00036-9","volume":"125","author":"K Kuge","year":"2003","unstructured":"Kuge K, Murakami G, Mizobuchi S, Hata Y, Aikou T, Sasaguri S. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg. 2003;125(6):1343\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"589_CR21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00276-006-0115-y","volume":"28","author":"M Mizutani","year":"2006","unstructured":"Mizutani M, Murakami G, Nawata S, Hitrai I, Kimura W. Anatomy of right recurrent nerve node: why does early metastasis of esophageal cancer occur in it? Surg Radiol Anat. 2006;28(4):333\u20138. doi: 10.1007\/s00276-006-0115-y .","journal-title":"Surg Radiol Anat"},{"issue":"1","key":"589_CR22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1442-2050.2010.01086.x","volume":"24","author":"Y Tachimori","year":"2011","unstructured":"Tachimori Y, Nagai Y, Kanamori N, Hokamura N, Igaki H. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus. 2011;24(1):33\u20138. doi: 10.1111\/j.1442-2050.2010.01086.x .","journal-title":"Dis Esophagus"},{"issue":"2c","key":"589_CR23","first-page":"1709","volume":"23","author":"Y Itoh","year":"2003","unstructured":"Itoh Y, Huwa N. Simultaneous combination of chemotherapy using protracted infusion of low-dose cisplatin and 5-fluorouracil with radiotherapy. Relationship between the size of the irradiation field and hemotoxicity. Anticancer Res. 2003;23(2c):1709\u201311.","journal-title":"Anticancer Res"},{"issue":"24","key":"589_CR24","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","volume":"326","author":"A Herskovic","year":"1992","unstructured":"Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326(24):1593\u20138. doi: 10.1056\/nejm199206113262403 .","journal-title":"N Engl J Med"},{"issue":"1019","key":"589_CR25","doi-asserted-by":"crossref","first-page":"e1110","DOI":"10.1259\/bjr\/12500248","volume":"85","author":"X Ding","year":"2012","unstructured":"Ding X, Zhang J, Li B, Wang Z, Huang W, Zhou T, et al. A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy. Br J Radiol. 2012;85(1019):e1110\u20139. doi: 10.1259\/bjr\/12500248 .","journal-title":"Br J Radiol"},{"issue":"3","key":"589_CR26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0003-4975(97)01387-8","volume":"65","author":"TW Rice","year":"1998","unstructured":"Rice TW, Zuccaro Jr G, Adelstein DJ, Rybicki LA, Blackstone EH, Goldblum JR. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg. 1998;65(3):787\u201392.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"589_CR27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjsurg.2005.07.035","volume":"191","author":"H Shimada","year":"2006","unstructured":"Shimada H, Nabeya Y, Matsubara H, Okazumi S, Shiratori T, Shimizu T, et al. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg. 2006;191(2):250\u20134. doi: 10.1016\/j.amjsurg.2005.07.035 .","journal-title":"Am J Surg"},{"issue":"3","key":"589_CR28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bjc.6604200","volume":"98","author":"EP Vliet van","year":"2008","unstructured":"van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98(3):547\u201357. doi: 10.1038\/sj.bjc.6604200 .","journal-title":"Br J Cancer"},{"issue":"8","key":"589_CR29","first-page":"1255","volume":"47","author":"S Yuan","year":"2006","unstructured":"Yuan S, Yu Y, Chao KS, Fu Z, Yin Y, Liu T, et al. Additional value of PET\/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. J Nucl Med. 2006;47(8):1255\u20139.","journal-title":"J Nucl Med"},{"issue":"17","key":"589_CR30","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJM199710233371702","volume":"337","author":"JR Izbicki","year":"1997","unstructured":"Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997;337(17):1188\u201394. doi: 10.1056\/nejm199710233371702 .","journal-title":"N Engl J Med"},{"issue":"4","key":"589_CR31","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejso.2012.01.007","volume":"38","author":"KL Prenzel","year":"2012","unstructured":"Prenzel KL, Holscher AH, Drebber U, Agavonova M, Gutschow CA, Bollschweiler E. Prognostic impact of nodal micrometastasis in early esophageal cancer. Eur J Surg Oncol. 2012;38(4):314\u20138. doi: 10.1016\/j.ejso.2012.01.007 .","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"589_CR32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1245\/s10434-008-0169-7","volume":"16","author":"AM Koenig","year":"2009","unstructured":"Koenig AM, Prenzel KL, Bogoevski D, Yekebas EF, Bubenheim M, Faithova L, et al. Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma. Ann Surg Oncol. 2009;16(2):454\u201362. doi: 10.1245\/s10434-008-0169-7 .","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"589_CR33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jso.10080","volume":"79","author":"T Nakamura","year":"2002","unstructured":"Nakamura T, Ide H, Eguchi R, Hayashi K, Ota M, Takasaki K. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma. J Surg Oncol. 2002;79(4):224\u20139. doi: 10.1002\/jso.10080 .","journal-title":"J Surg Oncol"},{"issue":"3","key":"589_CR34","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1365-2168.2001.01687.x","volume":"88","author":"F Sato","year":"2001","unstructured":"Sato F, Shimada Y, Li Z, Watanabe G, Maeda M, Imamura M. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg. 2001;88(3):426\u201332. doi: 10.1046\/j.1365-2168.2001.01687.x .","journal-title":"Br J Surg"},{"issue":"47","key":"589_CR35","doi-asserted-by":"crossref","first-page":"18022","DOI":"10.3748\/wjg.v20.i47.18022","volume":"20","author":"GW Ma","year":"2014","unstructured":"Ma GW, Situ DR, Ma QL, Long H, Zhang LJ, Lin P, et al. Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis. World J Gastroenterol. 2014;20(47):18022\u201330. doi: 10.3748\/wjg.v20.i47.18022 .","journal-title":"World J Gastroenterol"},{"key":"589_CR36","doi-asserted-by":"crossref","unstructured":"van der Schaaf M, Johar A, Wijnhoven B, Lagergren P, Lagergren J. Extent of lymph node removal during esophageal cancer surgery and survival. J Natl Cancer Inst. 2015;107(5). doi: 10.1093\/jnci\/djv043 .","DOI":"10.1093\/jnci\/djv043"},{"issue":"9","key":"589_CR37","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s11605-013-2259-5","volume":"17","author":"J Wong","year":"2013","unstructured":"Wong J, Weber J, Almhanna K, Hoffe S, Shridhar R, Karl R, et al. Extent of lymphadenectomy does not predict survival in patients treated with primary esophagectomy. J Gastrointest Surg. 2013;17(9):1562\u20138. doi: 10.1007\/s11605-013-2259-5 . discussion 9.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"589_CR38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1072-7515(98)00013-1","volume":"186","author":"T Nishimaki","year":"1998","unstructured":"Nishimaki T, Suzuki T, Suzuki S, Kuwabara S, Hatakeyama K. Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg. 1998;186(3):306\u201312.","journal-title":"J Am Coll Surg"},{"issue":"6","key":"589_CR39","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jtcvs.2006.07.039","volume":"132","author":"N Rizk","year":"2006","unstructured":"Rizk N, Venkatraman E, Park B, Flores R, Bains MS, Rusch V. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg. 2006;132(6):1374\u201381. doi: 10.1016\/j.jtcvs.2006.07.039 .","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"589_CR40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000658-200111000-00005","volume":"234","author":"S Natsugoe","year":"2001","unstructured":"Natsugoe S, Yoshinaka H, Shimada M, Sakamoto F, Morinaga T, Nakano S, et al. Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma. Ann Surg. 2001;234(5):613\u20138.","journal-title":"Ann Surg"},{"issue":"2","key":"589_CR41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.radonc.2010.10.021","volume":"98","author":"H Yamashita","year":"2011","unstructured":"Yamashita H, Okuma K, Wakui R, Kobayashi-Shibata S, Ohtomo K, Nakagawa K. Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma--a retrospective analysis. Radiother Oncol. 2011;98(2):255\u201360. doi: 10.1016\/j.radonc.2010.10.021 .","journal-title":"Radiother Oncol"},{"issue":"2","key":"589_CR42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2008.09.025","volume":"92","author":"M Onozawa","year":"2009","unstructured":"Onozawa M, Nihei K, Ishikura S, Minashi K, Yano T, Muto M, et al. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus. Radiother Oncol. 2009;92(2):266\u20139. doi: 10.1016\/j.radonc.2008.09.025 .","journal-title":"Radiother Oncol"},{"issue":"2","key":"589_CR43","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1245\/s10434-006-9141-6","volume":"14","author":"KL Prenzel","year":"2007","unstructured":"Prenzel KL, Konig A, Schneider PM, Schnickmann C, Baldus SE, Schroder W, et al. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer. Ann Surg Oncol. 2007;14(2):954\u20139. doi: 10.1245\/s10434-006-9141-6 .","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"589_CR44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.surg.2006.11.007","volume":"141","author":"J Matsuyama","year":"2007","unstructured":"Matsuyama J, Doki Y, Yasuda T, Miyata H, Fujiwara Y, Takiguchi S, et al. The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinomas of the thoracic esophagus. Surgery. 2007;141(5):570\u201380. doi: 10.1016\/j.surg.2006.11.007 .","journal-title":"Surgery"},{"issue":"3","key":"589_CR45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1442-2050.2002.00260.x","volume":"15","author":"Y Tsuchiya","year":"2002","unstructured":"Tsuchiya Y, Onda M, Sasajima K, Yamashita K, Nomura T, Makino H, et al. Effects of preoperative chemotherapy on metastatic lymph nodes in esophageal squamous cell carcinoma. Dis Esophagus. 2002;15(3):226\u201331.","journal-title":"Dis Esophagus"},{"issue":"7","key":"589_CR46","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","volume":"10","author":"SC Formenti","year":"2009","unstructured":"Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol. 2009;10(7):718\u201326. doi: 10.1016\/s1470-2045(09)70082-8 .","journal-title":"Lancet Oncol"},{"issue":"2","key":"589_CR47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1667\/RR13849.1","volume":"182","author":"MM Ahmed","year":"2014","unstructured":"Ahmed MM, Guha C, Hodge JW, Jaffee E. Immunobiology of radiotherapy: new paradigms. Radiat Res. 2014;182(2):123\u20135. doi: 10.1667\/rr13849.1 .","journal-title":"Radiat Res"},{"key":"589_CR48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1748-717X-7-200","volume":"7","author":"K Ji","year":"2012","unstructured":"Ji K, Zhao L, Yang C, Meng M, Wang P. Three-dimensional conformal radiation for esophageal squamous cell carcinoma with involved-field irradiation may deliver considerable doses of incidental nodal irradiation. Radiat Oncol. 2012;7:200. doi: 10.1186\/1748-717x-7-200 .","journal-title":"Radiat Oncol"},{"issue":"10","key":"589_CR49","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/jjco\/hyp069","volume":"39","author":"H Kato","year":"2009","unstructured":"Kato H, Sato A, Fukuda H, Kagami Y, Udagawa H, Togo A, et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol. 2009;39(10):638\u201343. doi: 10.1093\/jjco\/hyp069 .","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"589_CR50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.bjc.6600684","volume":"88","author":"K Kaneko","year":"2003","unstructured":"Kaneko K, Ito H, Konishi K, Kurahashi T, Ito T, Katagiri A, et al. Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus. Br J Cancer. 2003;88(1):18\u201324. doi: 10.1038\/sj.bjc.6600684 .","journal-title":"Br J Cancer"},{"issue":"6","key":"589_CR51","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjc.6603328","volume":"95","author":"P Michel","year":"2006","unstructured":"Michel P, Adenis A, Di Fiore F, Boucher E, Galais MP, Dahan L, et al. Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial. Br J Cancer. 2006;95(6):705\u20139. doi: 10.1038\/sj.bjc.6603328 .","journal-title":"Br J Cancer"},{"issue":"6","key":"589_CR52","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jjco\/hyt048","volume":"43","author":"K Kato","year":"2013","unstructured":"Kato K, Nakajima TE, Ito Y, Katada C, Ishiyama H, Tokunaga SY, et al. Phase II study of concurrent chemoradiotherapy at the dose of 50.4\u00a0Gy with elective nodal irradiation for Stage II-III esophageal carcinoma. Jpn J Clin Oncol. 2013;43(6):608\u201315. doi: 10.1093\/jjco\/hyt048 .","journal-title":"Jpn J Clin Oncol"},{"issue":"9","key":"589_CR53","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1200\/JCO.1999.17.9.2915","volume":"17","author":"A Ohtsu","year":"1999","unstructured":"Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, et al. Definitive chemoradiotherapy for T4 and\/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17(9):2915\u201321.","journal-title":"J Clin Oncol"},{"issue":"1","key":"589_CR54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0360-3016(01)02813-9","volume":"53","author":"Y Nishimura","year":"2002","unstructured":"Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y, Shigeoka H. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys. 2002;53(1):134\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"589_CR55","first-page":"231","volume":"19","author":"Y Itoh","year":"2001","unstructured":"Itoh Y, Fuwa N, Matsumoto A, Asano A, Morita K. Outcomes of radiotherapy for inoperable locally advanced (T4) esophageal cancer-retrospective analysis. Radiat Med. 2001;19(5):231\u20135.","journal-title":"Radiat Med"},{"issue":"22","key":"589_CR56","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P Hagen van","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074\u201384. doi: 10.1056\/NEJMoa1112088 .","journal-title":"N Engl J Med"},{"issue":"7","key":"589_CR57","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/cncr.21346","volume":"104","author":"PR Rohatgi","year":"2005","unstructured":"Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, et al. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer. 2005;104(7):1349\u201355. doi: 10.1002\/cncr.21346 .","journal-title":"Cancer"},{"issue":"1","key":"589_CR58","first-page":"45","volume":"6","author":"SH Lin","year":"2015","unstructured":"Lin SH, Wang J, Allen PK, Correa AM, Maru DM, Swisher SG, et al. A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer. J Gastrointest Oncol. 2015;6(1):45\u201352. doi: 10.3978\/j.issn.2078-6891.2014.054 .","journal-title":"J Gastrointest Oncol"},{"issue":"8","key":"589_CR59","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1440-1746.2006.04089.x","volume":"21","author":"H Ishikawa","year":"2006","unstructured":"Ishikawa H, Sakurai H, Tamaki Y, Nonaka T, Yamakawa M, Saito Y, et al. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy. J Gastroenterol Hepatol. 2006;21(8):1290\u20136. doi: 10.1111\/j.1440-1746.2006.04089.x .","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"589_CR60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiology.196.1.7784580","volume":"196","author":"T Okawa","year":"1995","unstructured":"Okawa T, Tanaka M, Kita-Okawa M, Nishio M, Kikuchi Y, Shirato H, et al. Superficial esophageal cancer: multicenter analysis of results of definitive radiation therapy in Japan. Radiology. 1995;196(1):271\u20134. doi: 10.1148\/radiology.196.1.7784580 .","journal-title":"Radiology"},{"issue":"6","key":"589_CR61","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/ajg.2011.42","volume":"106","author":"S Yamamoto","year":"2011","unstructured":"Yamamoto S, Ishihara R, Motoori M, Kawaguchi Y, Uedo N, Takeuchi Y, et al. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma. Am J Gastroenterol. 2011;106(6):1048\u201354. doi: 10.1038\/ajg.2011.42 .","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"589_CR62","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/cncr.26586","volume":"118","author":"J Welsh","year":"2012","unstructured":"Welsh J, Settle SH, Amini A, Xiao L, Suzuki A, Hayashi Y, et al. Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer. 2012;118(10):2632\u201340. doi: 10.1002\/cncr.26586 .","journal-title":"Cancer"},{"key":"589_CR63","author":"E Versteijne","year":"2014","unstructured":"Versteijne E, van Laarhoven HW, van Hooft JE, van Os RM, Geijsen ED, van Berge Henegouwen MI, et al. Definitive chemoradiation for patients with inoperable and\/or unresectable esophageal cancer: locoregional recurrence pattern. Dis Esophagus. 2014. doi: 10.1111\/dote.12215 .","journal-title":"Dis Esophagus"},{"issue":"5","key":"589_CR64","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1200\/JCO.2013.51.2186","volume":"32","author":"V Oppedijk","year":"2014","unstructured":"Oppedijk V, van der Gaast A, van Lanschot JJ, van Hagen P, van Os R, van Rij CM, et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol. 2014;32(5):385\u201391. doi: 10.1200\/JCO.2013.51.2186 .","journal-title":"J Clin Oncol"},{"issue":"26","key":"589_CR65","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.3748\/wjg.v12.i26.4185","volume":"12","author":"F Fiore Di","year":"2006","unstructured":"Di Fiore F, Lecleire S, Rigal O, Galais MP, Ben Soussan E, David I, et al. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol. 2006;12(26):4185\u201390.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"589_CR66","first-page":"2483","volume":"24","author":"T Uno","year":"2004","unstructured":"Uno T, Isobe K, Kawakami H, Ueno N, Kobayashi H, Shimada H, et al. Efficacy and toxicities of concurrent chemoradiation for elderly patients with esophageal cancer. Anticancer Res. 2004;24(4):2483\u20136.","journal-title":"Anticancer Res"},{"issue":"11","key":"589_CR67","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1159\/000334194","volume":"34","author":"JB Ma","year":"2011","unstructured":"Ma JB, Song YP, Yu JM, Zhou W, Cheng EC, Zhang XQ, et al. Feasibility of involved-field conformal radiotherapy for cervical and upper-thoracic esophageal cancer. Onkologie. 2011;34(11):599\u2013604. doi: 10.1159\/000334194 .","journal-title":"Onkologie"},{"issue":"2b","key":"589_CR68","first-page":"1507","volume":"26","author":"K Nemoto","year":"2006","unstructured":"Nemoto K, Yamada S, Nishio M, Aoki M, Nakamura R, Matsumoto Y, et al. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Anticancer Res. 2006;26(2b):1507\u201312.","journal-title":"Anticancer Res"},{"key":"589_CR69","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13014-014-0232-4","volume":"9","author":"M Liu","year":"2014","unstructured":"Liu M, Zhao K, Chen Y, Jiang GL. Evaluation of the value of ENI in radiotherapy for cervical and upper thoracic esophageal cancer: a retrospective analysis. Radiat Oncol. 2014;9:232. doi: 10.1186\/s13014-014-0232-4 .","journal-title":"Radiat Oncol"},{"issue":"4","key":"589_CR70","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1016\/j.ijrobp.2011.04.032","volume":"81","author":"FM Hsu","year":"2011","unstructured":"Hsu FM, Lee JM, Huang PM, Lin CC, Hsu CH, Tsai YC, et al. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2011;81(4):e593\u20139. doi: 10.1016\/j.ijrobp.2011.04.032 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"14","key":"589_CR71","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1200\/JCO.2003.03.055","volume":"21","author":"S Ishikura","year":"2003","unstructured":"Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 2003;21(14):2697\u2013702. doi: 10.1200\/jco.2003.03.055 .","journal-title":"J Clin Oncol"},{"issue":"3","key":"589_CR72","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","volume":"15","author":"T Conroy","year":"2014","unstructured":"Conroy T, Galais MP, Raoul JL, Bouch\u00e9 O, Gourgou-Bourgade S, Douillard JY, et al. Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3 trial. Lancet Oncol. 2014;15(3):305\u201314. doi: 10.1016\/S1470-2045(14)70028-2 .","journal-title":"Lancet Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-016-0589-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T08:37:58Z","timestamp":1567586278000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ro-journal.com\/content\/11\/1\/18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s13014-016-0589-7","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]},"article-number":"18"}}